Xymelin Eco with menthol spray naz. 0.1% fl. 10 ml

Transparent or slightly opalescent, colorless or slightly colored liquid with a characteristic odor

Pharmaco-therapeutic group

N4 Acute respiratory diseases with symptoms of rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa).

Preparing the patient for diagnostic manipulations in the nasal passages.

Application during pregnancy and during breastfeeding

The use of the drug is contraindicated in pregnancy.

During the period of breastfeeding, the drug should be used only after a careful assessment of the risk-benefit ratio for mother and child, under the supervision of a physician.

Do not exceed the recommended dosage.

Dosage form

Dosed nasal spray 140 mcg / dose.

10 ml of the drug (at least 60 doses) in a plastic bottle equipped with a pump dosing device with a tip and a protective cap made of polyethylene.

1 bottle with instructions for use is placed in a cardboard box.

Shelf life

2.5 years.

Do not use after the expiration date.

Category

Symptomatic drugs

Name ENG

XYMELIN ECO WITH MENTHOL

Clinical and pharmacological group

A vasoconstrictor drug for local use in ENT practice

ATX code

Xylometazoline

Dosage

140mcg / dose x 10ml

Structure

1 dose contains: Active ingredient: xylometazoline hydrochloride 140 mcg Excipients: sorbitol 1.96 mg hydrogenated castor oil 350 mcg levomenthol 42 mcg cineol (eucalyptol) 28 mcg sodium chloride 728 mcg sodium hydrogen phosphate dihydrate 280 mcg sodium dihydrogen phosphate dihydrate 70 mcg purified water up to 140 mcl

Indications

acute respiratory diseases with symptoms of rhinitis (rhinitis)

acute allergic rhinitis

hay fever

sinusitis

eustachitis

otitis media (to reduce swelling of the nasopharyngeal mucosa)

preparation of the patient for diagnostic manipulations in the nasal passages.

INN / Active ingredient

xylometazoline

Storage conditions and periods

At a temperature not higher than 30 ° C.

Keep out of the reach of children.

Contraindications

Hypersensitivity to xylometazoline and other components of the drug, arterial hypertension, tachycardia, severe atherosclerosis, glaucoma, dry rhinitis or atrophic rhinitis, hyperthyroidism, condition after transsphenoidal hypophysectomy, surgical interventions on the meninges (in history), pregnancy, childhood.

Do not use the drug during therapy with monoamine oxidase inhibitors or tricyclic antidepressants, including a period of 14 days after their withdrawal.

Specifications

Category

Runny nose

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Germany

Scope of application

Virology

Minimum age from

6 years

Way of introduction

Through the respiratory tract

Vacation conditions

Without recipe

Volume, ml.

10 ml

Brand name

Takeda

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

R01AA07 Xylometazoline

Dosage form

Dosed nasal spray

The target audience

Children

Expiration date in days

912

Dosage (volume) of the substance in the preparation

xylometazoline hydrochloride 1 mg

Package weight, g

twenty

Mode of application

:

Intranasally.

For adults and children over 10 years old: 1 injection in each nasal passage (if necessary, you can repeat it)

should not be applied more than 3 times a day.

The duration of treatment is no more than 10 days.

Pharmaco-therapeutic group

:

Decongestant - vasoconstrictor (alpha-adrenergic agonist)